Skip to main content
Carl Zeiss Meditec AG logo

Carl Zeiss Meditec AG — Investor Relations & Filings

Ticker · AFX ISIN · DE0005313704 LEI · 529900GRL4MZ8NMOOK95 F Manufacturing
Filings indexed 529 across all filing types
Latest filing 2024-08-16 Interim / Quarterly Rep…
Country DE Germany
Listing F AFX

About Carl Zeiss Meditec AG

https://www.zeiss.com/meditec-ag/en/hom…

Carl Zeiss Meditec AG is a leading global medical technology company with two strategic business units: Ophthalmology and Microsurgery. The Ophthalmology unit offers a comprehensive portfolio for the diagnosis and treatment of eye diseases, including diagnostic systems, surgical lasers, and intraocular lenses. The Microsurgery unit provides innovative visualization solutions, such as surgical microscopes, for medical disciplines including neurosurgery, spinal surgery, ENT, and dentistry. The company's technologies and application-oriented solutions are designed to help doctors improve the quality of life of their patients and advance medical progress.

Recent filings

Filing Released Lang Actions
Q3 statement / Q3 financial report 2023/2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report 9 Months 2023/24' and contains detailed financial statements, including consolidated income statements, cash flow summaries, and business development analysis for the Carl Zeiss Meditec Group. It provides substantive financial data for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report, as it contains the full content of the interim results. 9M 2024
2024-08-16 English
Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
Earnings Release Classification · 1% confidence The document is explicitly titled with 'EQS-News' and contains key phrases like '9 Month figures/Quarterly / Interim Statement'. It reports financial performance ('revenue of around €1,486.5m', 'EBIT declined to around €162.7m') for the 'first nine months of fiscal year 2023/24'. This structure and content strongly indicate a comprehensive financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it provides detailed segment and regional breakdowns, which are characteristic of a more comprehensive report, not just the initial highlights. 9M 2024
2024-08-06 English
Report Publication Announcement 2024
Report Publication Announcement Classification · 1% confidence The document is titled "Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that Carl Zeiss Meditec AG is announcing *when* and *where* specific financial reports (Quarterly/Interim statement) will be disclosed on August 06, 2024, and provides direct links to those future reports. This structure—an announcement about the upcoming release of a report rather than the report itself—perfectly matches the definition of a Report Publication Announcement (RPA). The document length (2064 chars) is also short, supporting the 'MENU VS MEAL' rule.
2024-07-30 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.10.2023 bis zum 30.06.2024
Report Publication Announcement Classification · 1% confidence The document is a short notification (858 characters) announcing the availability of a financial report (Zwischenmitteilung) and providing a URL link to the actual document. According to the 'Menu vs Meal' rule, since this is an announcement of a report's publication rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2024-07-30 German
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.10.2023 bis zum 30.06.2024
Report Publication Announcement Classification · 1% confidence The document is very short (877 characters) and explicitly functions as a notice ('Hinweis auf Zwischenmitteilung'). It states that the 'Finanzbericht' (Financial Report) is available on the internet via a specific link and provides the date it was made available (06.08.2024). This structure—announcing the availability of a detailed report rather than containing the report itself—fits the definition of a Report Publication Announcement (RPA). The report being announced is an 'Zwischenmitteilung' (Interim Statement), which would typically be classified as an Interim/Quarterly Report (IR), but since this document is only the notice, RPA is the correct classification based on Rule 2 (The 'MENU VS MEAL' Rule).
2024-07-30 German
Ergänzung der Veröffentlichung vom 29.01.2024
Notice of Dividend Amount Classification · 1% confidence The document is a short announcement regarding the 'Beschluss über die Gewinnverwendung' (Resolution on the appropriation of profit) for Carl Zeiss Meditec AG, specifically detailing the dividend payment of EUR 1.10 per share. It is not the full annual report itself, but rather a specific notice regarding dividend distribution and profit allocation following an AGM. Therefore, it fits the 'Notice of Dividend Amount' category. FY 2023
2024-06-25 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.